IFP Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.6K | Hold |
1,109
| – | – | ﹤0.01% | 2444 |
|
|
2026
Q1 | $29.3K | Sell |
1,109
-804
| -42% | -$23.5K | ﹤0.01% | 2566 |
|
|
2025
Q4 | $55.4K | Sell |
1,913
-8
| -0.4% | -$240 | ﹤0.01% | 2140 |
|
|
2025
Q3 | $53.3K | Sell |
1,921
-317
| -14% | -$8.01K | ﹤0.01% | 2043 |
|
|
2025
Q2 | $54.5K | Sell |
2,238
-92
| -4% | -$2.02K | ﹤0.01% | 2001 |
|
|
2025
Q1 | $48.4K | Sell |
2,330
-200
| -8% | -$5.03K | ﹤0.01% | 1907 |
|
|
2024
Q4 | $59.6K | Sell |
2,530
-250
| -9% | -$6.15K | ﹤0.01% | 1742 |
|
|
2024
Q3 | $71.2K | Sell |
2,780
-2,919
| -51% | -$74.3K | ﹤0.01% | 1562 |
|
|
2024
Q2 | $134K | Buy |
5,699
+409
| +8% | +$10.3K | 0.01% | 1231 |
|
|
2024
Q1 | $152K | Buy |
5,290
+400
| +8% | +$12K | 0.01% | 1127 |
|
|
2023
Q4 | $160K | Buy |
4,890
+2,537
| +108% | +$69K | 0.01% | 1056 |
|
|
2023
Q3 | $65.6K | Sell |
2,353
-2,098
| -47% | -$68.6K | ﹤0.01% | 1445 |
|
|
2023
Q2 | $152K | Sell |
4,451
-701
| -14% | -$22K | 0.01% | 1145 |
|
|
2023
Q1 | $149K | Sell |
5,152
-7,493
| -59% | -$232K | 0.01% | 1064 |
|
|
2022
Q4 | $371K | Sell |
12,645
-948
| -7% | -$30.1K | 0.01% | 1030 |
|
|
2022
Q3 | $400K | Buy |
13,593
+6
| +0% | +$220 | 0.01% | 1029 |
|
|
2022
Q2 | $401K | Hold |
13,587
| – | – | 0.01% | 934 |
|
|
2022
Q1 | $401K | Buy |
13,587
+4,311
| +46% | +$206K | 0.01% | 934 |
|
|
2021
Q4 | $572K | Sell |
9,276
-11,170
| -55% | -$772K | 0.01% | 549 |
|
|
2021
Q3 | $1.52M | Buy |
20,446
+11,685
| +133% | +$980K | 0.03% | 312 |
|
|
2021
Q2 | $810K | Sell |
8,761
-5,374
| -38% | -$457K | 0.02% | 419 |
|
|
2021
Q1 | $1.26M | Buy |
14,135
+5,559
| +65% | +$551K | 0.02% | 324 |
|
|
2020
Q4 | $799K | Sell |
8,576
-1,277
| -13% | -$102K | 0.03% | 390 |
|
|
2020
Q3 | $630K | Buy |
9,853
+5,557
| +129% | +$326K | 0.04% | 383 |
|
|
2020
Q2 | $219K | Buy |
4,296
+1,604
| +60% | +$68.8K | 0.02% | 632 |
|
|
2020
Q1 | $88K | Buy |
2,692
+1,970
| +273% | +$65.8K | 0.01% | 884 |
|
|
2019
Q4 | $25K | Buy |
722
+540
| +297% | +$17.2K | ﹤0.01% | 1523 |
|
|
2019
Q3 | $6K | Buy |
+182
| New | +$5.92K | ﹤0.01% | 2263 |
|
|
2019
Q1 | $6K | Sell |
198
-3,584
| -95% | -$106K | ﹤0.01% | 1775 |
|
|
2018
Q4 | $88K | Sell |
3,782
-525
| -12% | -$14.8K | 0.01% | 1266 |
|
|
2018
Q3 | $144K | Buy |
4,307
+847
| +24% | +$26.8K | 0.01% | 1262 |
|
|
2018
Q2 | $101K | Sell |
3,460
-290
| -8% | -$8.07K | ﹤0.01% | 1475 |
|
|
2018
Q1 | $92K | Hold |
3,750
| – | – | ﹤0.01% | 1431 |
|
|
2017
Q4 | $92K | Sell |
3,750
-237
| -6% | -$6K | ﹤0.01% | 1443 |
|
|
2017
Q3 | $105K | Buy |
3,987
+3,090
| +344% | +$72.7K | ﹤0.01% | 1521 |
|
|
2017
Q2 | $20K | Buy |
+897
| New | +$18.7K | ﹤0.01% | 2574 |
|
|
2016
Q2 | – | Sell |
-198
| Closed | -$6K | – | 3825 |
|
|
2016
Q1 | $6K | Buy |
+198
| New | +$3.39K | ﹤0.01% | 1775 |
|
Other funds holding ARKG
JFG
IFP Advisors's ARKG Position: Q2 2026 in Review
IFP Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 1,109 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2444.
IFP Advisors first reported a position in ARKG in Q1 2016 and has held it in 37 quarters since. The position peaked at $1.52M in Q3 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- IFP Advisors held 1,109 shares of ARK Genomic Revolution ETF worth $46.6K as of Q2 2026.
- IFP Advisors left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2444 holding.
- IFP Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2016 and has held it in 37 quarters since.
- IFP Advisors's ARK Genomic Revolution ETF position peaked at $1.52M in Q3 2021.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.